105 results
8-K
EX-99.2
VANI
Vivani Medical Inc
13 May 24
Vivani Medical Provides Business Update and Reports First Quarter 2024 Financial Results
4:57pm
monotherapy may provide adequate weight loss for the majority of patients2 Preclinical data with NPM-115 has demonstrated similar magnitude of weight loss
8-K
EX-99.2
iv7e 81mkjjhex
26 Mar 24
Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2023 Financial Results
8:31am
8-K
EX-4.1
b4wtpanmj9 v0lhzb6
5 Mar 24
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
4:21pm
8-K
EX-10.2
0va76mc0y ciog8mu
5 Mar 24
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
4:21pm
8-K
EX-10.1
8e2 hlxbplh63bk6m
5 Mar 24
Vivani Medical Announces Pricing of $15.0 Million Registered Direct Offering of Common Stock and Warrants
4:21pm
424B5
u0y5xblp i961r
5 Mar 24
Prospectus supplement for primary offering
11:31am
8-K
EX-99.2
8pwgkg4no6
28 Feb 24
Regulation FD Disclosure
8:30am
8-K
EX-99.1
sduk1ze9n
14 Nov 23
Results of Operations and Financial Condition
6:06am
8-K
qcv5o
10 Jul 23
Material Modifications to Rights of Security Holders
4:04pm
8-K
EX-3.2
p7tgwinb
10 Jul 23
Material Modifications to Rights of Security Holders
4:04pm